Medical Devices Research Blood Banking Devices Market | Page 2

REPORT DESCRIPTION
Blood Banking Devices Market - Insights
The Global Blood Banking Devices Market, by Product Type (Blood Collection Devices (Blood
Collection Needles, Blood Collection Tubes (Serum Collection Tubes, Plasma Collection Tubes,
Heparin Tubes, and Other Tubes), Needles & Syringes, Lancets, Vacuum Blood Collection System,
Blood Bags, and Accessories), Blood Processing Devices (Blood Grouping Analyzers, Blood Cell
Processors, Blood Filters, Centrifuges, and Others), and Blood Storage Devices (Blood Bank
Refrigerators and Blood Bank Freezers)), by Method of Collection (Manual Blood Collection and
Automated Blood Collection), End User (Blood Banks, Hospitals and Other End Users), and Region
(North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued US$
28.1 billion in 2018 and is projected to exhibit a CAGR of 7.4% over the forecast period (2018 -
2026), as highlighted in a new report published by Coherent Market Insights.
Request Sample: https://www.coherentmarketinsights.com/insight/request-sample/1980
Key players operating in the market are adopting strategies such as mergers and acquisitions
to gain competitive edge in the blood banking devices market. For instance, in January 2017,
Hologic, Inc. completed the divestiture of its blood screening business to Grifols for deal
value of US$ 1.85 billion. This divestment will help Hologic to significantly accelerate their
financial flexibility.
In January 2017, Werfen and its subsidiary Instrumentation Laboratory (IL) announced the
acquisition of Accriva Diagnostics, a company engaged in in-vitro diagnostic (IVD) blood
testing at the point-of-care (POC), including their innovative product portfolio spanning
coagulation, platelet aggregation, CO-Oximetry, and incision devices.
© Coherent market Insights. All Rights Reserved